Dr. Debra A. Goldstein, MD

Dr. Goldstein practices at Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois.

Dr. Goldstein's NPI, 1679629778, was assigned on January 25, 2007. Dr. Goldstein holds Illinois license 036-088837.

Dr. Goldstein's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD, at 259 E Erie St, Chicago, IL 60611.

Dr. Goldstein's primary practice is Northwestern Memorial Hospital - Lavin Family Pavilion Recovery Room - HOPD in Chicago, Illinois. Dr. Goldstein is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Goldstein to 1 more group practice or clinic, named with a free account. Dr. Goldstein's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstein practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Goldstein's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Goldstein is licensed in Illinois.

CMS data shows 449 Medicare services from Dr. Goldstein across 4 procedure codes in 2024, for 120 Medicare patients. Medicare paid $32,614 for them. Every service was in an office.

CMS counts 120 Medicare patients who saw Dr. Goldstein in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goldstein's median patient age at 54, with 69% women.

In 2024, Dr. Goldstein wrote 306 Medicare Part D claims for 79 patients. 65% of them were for generic drugs. CMS names the drug for 223 of them, across 8 drugs with 11 or more claims each, at $23,078 in total drug cost. In 2023, CMS named 101 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Goldstein for performance year 2024, reported through an alternative payment model (APM). Dr. Goldstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 129 papers to Dr. Goldstein, published from 2011 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Uveitis, Tomography, Optical Coherence and Visual Acuity. Dr. Goldstein has published most often in Ocul Immunol Inflamm. Dr. Goldstein's most frequent co-authors are Anjum F. Koreishi, MD, Timothy Milton Janetos, MBA, MD and Jennifer Elizabeth Thorne, MD.

CMS Open Payments shows 91 general payments to Dr. Goldstein from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Abbvie Inc. paid the most, $72,790. It also lists 10 research payments totaling $14,607 from 2016 to 2017.